Reviews reflect personal experiences and are not medical advice. Always consult your doctor.
Manufacturer
新竹物流股份有限公司 (TW)
ATC Code
S01BA14
Source
TFDA
S01BA14(WHO)
AU:S4(Prescription only)US:℞-only
Chloromethyl 17-ethoxycarbonyloxy-11-hydroxy-10,13-dimethyl-3-oxo-7,8,9,11,12,14,15,16-octahydro-6H-cyclopenta[a]phenanthrene-17-carboxylate
82034-46-6Y
444025
7085
DB14596N
392049N
YEH1EZ96K6
D01689Y
CHEBI:31784N
ChEMBL1200865N
DTXSID10156128
Interactive image
CCOC(=O)O[C@@]1(CC[C@@H]2[C@@]1(C[C@@H]([C@H]3[C@H]2CCC4=CC(=O)C=C[C@]34C)O)C)C(=O)OCCl
InChI=1S/C24H31ClO7/c1-4-30-21(29)32-24(20(28)31-13-25)10-8-17-16-6-5-14-11-15(26)7-9-22(14,2)19(16)18(27)12-23(17,24)3/h7,9,11,16-19,27H,4-6,8,10,12-13H2,1-3H3/t16-,17-,18-,19+,22-,23-,24-/m0/s1NKey:DMKSVUSAATWOCU-HROMYWEYSA-NN
Loteprednol(formulated as theesterloteprednol etabonate) is a topicalcorticosteroidused to treat inflammations of the eye. It is marketed byBausch and LombasLotemaxandLoterex.
It was patented in 1980 and approved for medical use in 1998.It is available as ageneric medication.
⚠️ Warnings
•May mask and exacerbate existing ocular infection.
• Re-evaluate patients if symptoms do not improve after 2 days.
It may cause blurred vision, do not drive a car or operate machinery while taking this medication.
Do not wear soft contact lenses while using this medication.